Leonard Bacharier

Professor of Pediatrics

Vanderbilt University Medical Center

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Leonard Bacharier is a Professor of Pediatrics at Vanderbilt University Medical Center in the United States. His research primarily focuses on pediatric asthma, exploring topics such as severe asthma management, the effects of biologics, and the role of environmental factors like particulate matter on lung function. Recent publications include studies on asthma guidelines, biomarkers for asthma prognosis, and the impact of vitamin D on asthma exacerbations in children.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (8)

Rachel Robison

Associate Professor

Vanderbilt University Medical Center

UNITED STATES

View details

Bianca Prof. Dr. med. Schaub

Professorship

Ludwig-Maximilians-Universität München

GERMANY

View details

Liesbeth Duijts

NETHERLANDS

View details

Yueh-Ying Han

Research Associate Professor

University of Pittsburgh

UNITED STATES

View details

Jeffrey Drazen

Distinguished Parker B. Francis Professor of Medicine

Harvard Medical School

UNITED STATES

View details

Carla Davis

Baylor College of Medicine Department of Pediatrics

UNITED STATES

View details

Juan C. Celedón

UNITED STATES

View details

Seyed Mehdi Nouraie

Associate Professor

University of Pittsburgh

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Leonard Bacharier

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

An Algorithm for the Diagnosis and Management of Severe Asthma in Children and Adolescents

Vitamin D Supplementation, Long-Term PM2.5 Exposure, and Severe Asthma Exacerbations in Children with Low Vitamin D: A Post Hoc Analysis of a Double-Blind, Randomized, Placebo-controlled Trial (VDKA)

Dupilumab Plus Medium‐Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High‐Dose ICS in Children With Uncontrolled Moderate‐to‐Severe Type 2 Asthma

Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma

The biologic asthma response score

Long-Term Exposure to Particulate Matter <2.5 μm and Lung Function Change in Children with Asthma Receiving Inhaled Corticosteroids

Biologics in the treatment of asthma in children and adolescents

Reply to Baraldi and Piacentini: Global Initiative for Asthma 2021: Asthma in Preschool Children and Short-Acting β2-Agonist–Only Treatment

Asthma guidelines: Where to next?

Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes

Global Initiative for Asthma Strategy 2021

Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes

Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes

Asthma is associated with lower respiratory tract involvement and worse clinical score in children with COVID‐19

Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation.

Collaborators (8)

Rachel Robison

Bianca Prof. Dr. med. Schaub

Liesbeth Duijts

Yueh-Ying Han

Jeffrey Drazen

Carla Davis

Juan C. Celedón

Seyed Mehdi Nouraie

Make your next move.